JP2017528734A5 - - Google Patents

Download PDF

Info

Publication number
JP2017528734A5
JP2017528734A5 JP2017527543A JP2017527543A JP2017528734A5 JP 2017528734 A5 JP2017528734 A5 JP 2017528734A5 JP 2017527543 A JP2017527543 A JP 2017527543A JP 2017527543 A JP2017527543 A JP 2017527543A JP 2017528734 A5 JP2017528734 A5 JP 2017528734A5
Authority
JP
Japan
Prior art keywords
lymphocytes
lymphocyte
level
individual
blood sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017527543A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017528734A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/044372 external-priority patent/WO2016023006A1/en
Publication of JP2017528734A publication Critical patent/JP2017528734A/ja
Publication of JP2017528734A5 publication Critical patent/JP2017528734A5/ja
Pending legal-status Critical Current

Links

JP2017527543A 2014-08-08 2015-08-07 診断用バイオマーカーとしての抗リンパ球自己抗体 Pending JP2017528734A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462035073P 2014-08-08 2014-08-08
US62/035,073 2014-08-08
PCT/US2015/044372 WO2016023006A1 (en) 2014-08-08 2015-08-07 Anti-lymphocyte autoantibodies as diagnostic biomarkers

Publications (2)

Publication Number Publication Date
JP2017528734A JP2017528734A (ja) 2017-09-28
JP2017528734A5 true JP2017528734A5 (enExample) 2018-08-09

Family

ID=55264686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017527543A Pending JP2017528734A (ja) 2014-08-08 2015-08-07 診断用バイオマーカーとしての抗リンパ球自己抗体

Country Status (7)

Country Link
US (1) US9709564B2 (enExample)
EP (1) EP3177930A1 (enExample)
JP (1) JP2017528734A (enExample)
CN (1) CN107110861A (enExample)
BR (1) BR112017002575B1 (enExample)
RU (1) RU2017107273A (enExample)
WO (1) WO2016023006A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017023781A1 (en) 2015-07-31 2017-02-09 Allegheny-Singer Research Institute Cell-bound complement activation product assays as companion diagnostics for antibody-based drugs
KR101674018B1 (ko) * 2016-05-16 2016-11-08 (주)글로리바이오텍 Cd4, cd8 세포 정보를 이용한 hiv 진단 방법
AU2017269968B2 (en) * 2016-05-24 2024-02-01 Allegheny-Singer Research Institute Methods and systems using C4 gene copy number and cell-bound complement activation products for identification of lupus and pre-lupus
CA3170448A1 (en) * 2020-09-28 2022-03-31 Joseph M. Ahearn Methods for determining a level of a cell fragment-bound complement activation product

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005108988A2 (en) * 2004-04-09 2005-11-17 University Of Pittsburgh Real time method of detecting acute inflammatory conditions
DK1745287T3 (da) * 2004-05-11 2011-01-24 Univ Pittsburgh Diagnostisering og monitorering af inflammatoriske sygdomme ved at måle komplementkomponenter på hvide blodlegemer
CA2738952A1 (en) * 2008-10-16 2010-04-22 Cypress Bioscience, Inc. Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (sle) and other autoimmune diseases
ES2560809T3 (es) * 2010-02-12 2016-02-22 Yeda Research And Development Co. Ltd. Diagnóstico de lupus eritematoso sistémico
US10132813B2 (en) * 2011-02-11 2018-11-20 Exagen Diagnostics, Inc. Methods for diagnosing systemic lupus erythematosus
CN102818890A (zh) * 2011-06-10 2012-12-12 苏州卫生职业技术学院 一种检测系统性红斑狼疮患者自身抗体的方法
PT2791675T (pt) * 2011-12-13 2018-07-27 Baxalta Inc Medição de autoanticorpos em condições de baixa condutividade
WO2014020357A1 (en) 2012-08-02 2014-02-06 Sense Proteomic Limited Auto-antigen biomarkers for lupus
WO2014093268A1 (en) 2012-12-10 2014-06-19 Allegheny-Singer Research Institute Methods and systems for using complement-tagged molecules as biomarkers of disease
BR112015018964B1 (pt) 2013-02-08 2022-08-02 Allegheny-Singer Research Institute Método para determinar se um paciente se classifica como não apresentando ter lupus e sistema para executar o método para determinar se um paciente se classifica como não apresentando ter lupus
CN103439517A (zh) * 2013-09-11 2013-12-11 河北省健海生物芯片技术有限责任公司 一种系统性红斑狼疮自身抗体检测装置

Similar Documents

Publication Publication Date Title
Mathieu et al. Immunological biomarkers for the development and progression of type 1 diabetes
Csernok et al. Current and emerging techniques for ANCA detection in vasculitis
La Manna et al. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease
CN106442984B (zh) 区分细菌与病毒感染的标记物和决定因素以及其使用方法
Bae et al. Comparison of the sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT. TB according to patient age
JP2016507066A5 (enExample)
JP2014505264A5 (enExample)
Yamamoto-Furusho et al. Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis
Kim et al. Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy
BR112012017014A8 (pt) métodos para detecção de anticorpos de vírus jc
Bertolo et al. Deep phenotyping of urinary leukocytes by mass cytometry reveals a leukocyte signature for early and non-invasive prediction of response to treatment in active lupus nephritis
JP2008178421A (ja) リンパ球機能の測定方法
JP2017528734A5 (enExample)
Kuuliala et al. Constitutive STAT3 phosphorylation in circulating CD4+ T lymphocytes associates with disease activity and treatment response in recent-onset rheumatoid arthritis
Valle-Arroyo et al. Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact
Mancebo et al. High proportion of CD95+ and CD38+ in cultured CD8+ T cells predicts acute rejection and infection, respectively, in kidney recipients
RU2017107273A (ru) Антилимфоцитарные аутоантитела в качестве диагностических биомаркеров
McLeish et al. Uncovering the significance of expanded CD8+ large granular lymphocytes in inclusion body myositis: Insights into T cell phenotype and functional alterations, and disease severity
Lanzillo et al. JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level
Shin et al. Decreased PD-1 positive blood follicular helper T cells in patients with psoriasis
Zecevic et al. Potential immune biomarkers in diagnosis and clinical management for systemic lupus erythematosus
Amador-Ortiz et al. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma
CN106568977A (zh) 血清中sIL‑7R在诊断系统性红斑狼疮肾炎中的应用
Xia et al. Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation
Cromar et al. Detection of acetylcholine receptor blocking antibodies by flow cytometry